SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201 | -56.1% | 9,744 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $458 | +12.0% | 9,744 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $409 | +9.9% | 9,744 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $372 | -99.9% | 9,744 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $382,000 | +21.3% | 9,744 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $315,000 | -2.5% | 9,744 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $323,000 | -22.2% | 9,744 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $415,000 | -3.9% | 9,744 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $432,000 | -22.0% | 9,744 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $554,000 | -25.5% | 9,744 | -2.0% | 0.00% | -25.0% |
| Q1 2021 | $744,000 | -13.5% | 9,944 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $860,000 | +72.7% | 9,944 | +22.1% | 0.01% | +25.0% |
| Q3 2020 | $498,000 | -26.5% | 8,144 | -50.0% | 0.00% | +33.3% |
| Q2 2020 | $678,000 | -39.2% | 16,288 | +16.3% | 0.00% | -89.3% |
| Q2 2017 | $1,115,000 | -12.8% | 14,000 | -22.2% | 0.03% | -22.2% |
| Q1 2017 | $1,279,000 | – | 18,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |